Using proteomics and bioinformatics techniques, CAV1 has been identified as a major network-centric protein between gastric cancer-associated fibroblasts (GCAFs) and their corresponding inflammation-associated fibroblasts (GIAFs) which was later validated using IHC40. The gene discussed is CAV1; the disease is gastric cancer.